We studied cognitively impaired (CI) Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with T1‐magnetic resonance imaging (MRI) and amyloid‐ and tau‐positron emission tomography (PET). Here, MAPT is linked to Alzheimer disease.